135 related articles for article (PubMed ID: 19484491)
1. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.
Galoian K; Scully S; McNamara G; Flynn P; Galoyan A
Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491
[TBL] [Abstract][Full Text] [Related]
2. Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.
Galoian K; Scully S; Galoyan A
Neurochem Res; 2009 Feb; 34(2):379-85. PubMed ID: 18612811
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
Galoian K; Temple TH; Galoyan A
Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
[TBL] [Abstract][Full Text] [Related]
5. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
Galoian K; Abrahamyan S; Chailyan G; Qureshi A; Patel P; Metser G; Moran A; Sahakyan I; Tumasyan N; Lee A; Davtyan T; Chailyan S; Galoyan A
Int J Oncol; 2018 Jan; 52(1):139-154. PubMed ID: 29138803
[TBL] [Abstract][Full Text] [Related]
6. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract][Full Text] [Related]
7. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract][Full Text] [Related]
8. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
[TBL] [Abstract][Full Text] [Related]
10. Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.
Galoian K; Qureshi A; Wideroff G; Temple HT
Mol Clin Oncol; 2015 Jan; 3(1):171-178. PubMed ID: 25469290
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.
Galoian K; Luo S; Qureshi A; Patel P; Price R; Morse AS; Chailyan G; Abrahamyan S; Temple HT
Mol Clin Oncol; 2016 Nov; 5(5):618-624. PubMed ID: 27900099
[TBL] [Abstract][Full Text] [Related]
12. Survival of trauma-injured neurons in rat brain by treatment with proline-rich peptide (PRP-1): an immunohistochemical study.
Abrahamyan SS; Sarkissian JS; Meliksetyan IB; Galoyan AA
Neurochem Res; 2004 Apr; 29(4):695-708. PubMed ID: 15098931
[TBL] [Abstract][Full Text] [Related]
13. Morpho‑functional study of the hypothalamic proline‑rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma.
Abrahamyan S; Sahakyan I; Tumasyan N; Kocharyan N; Simonyan A; Aroutiounian R; Chailyan G; Chailyan S; Davtyan T; Galoian K
Oncol Rep; 2020 Jul; 44(1):196-212. PubMed ID: 32377754
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic proline rich polypeptide regulates hematopoiesis.
Bezirganyan KB; Davtyan TK; Galoyan AA
Neurochem Res; 2010 Jun; 35(6):917-24. PubMed ID: 20020325
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic proline-rich polypeptide enhances bone marrow colony-forming cell proliferation and stromal progenitor cell differentiation.
Galoyan AA; Korochkin LI; Rybalkina EJ; Pavlova GV; Saburina IN; Zaraiski EI; Galoyan NA; Davtyan TK; Bezirganyan KB; Revishchin AV
Cell Transplant; 2008; 17(9):1061-6. PubMed ID: 19177842
[TBL] [Abstract][Full Text] [Related]
16. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line.
Lai TJ; Hsu SF; Li TM; Hsu HC; Lin JG; Hsu CJ; Chou MC; Lee MC; Yang SF; Fong YC
Acta Pharmacol Sin; 2007 Aug; 28(8):1231-5. PubMed ID: 17640487
[TBL] [Abstract][Full Text] [Related]
17. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypothalamic proline-rich peptide (PRP-1) on neuronal and bone marrow cell apoptosis.
Galoyan AA; Krieglstein J; Klumpp S; Danielian KE; Galoian KA; Kremers W; Bezirganyan KB; Davtyan TK
Neurochem Res; 2007 Nov; 32(11):1898-905. PubMed ID: 17549627
[TBL] [Abstract][Full Text] [Related]
19. Influence of hypothalamic proline-rich peptide on the level of [14C]glucose utilization during crush syndrome.
Kevorkian GA; Marukhyan GL; Arakelyan LN; Guevorkian AG; Galoyan AA
Neurochem Res; 2001 Jul; 26(7):829-32. PubMed ID: 11565615
[TBL] [Abstract][Full Text] [Related]
20. Effect of hypothalamic proline-rich-polypeptide on voltage-gated Ca2+ currents in retinal ganglion cells.
Akopian A; Galoyan A
Neurochem Res; 2003 Dec; 28(12):1867-71. PubMed ID: 14649729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
